Fungal biotransformation of tanshinone results in [4+2] cycloaddition with sorbicillinol: evidence for enzyme catalysis and increased antibacterial activity

By Wenni He, Miaomiao Liu, Xiaolin Li, Xiaoping Zhang, Wael M. Abdel-Mageed, Li Li, Wenzhao Wang, Jingyu Zhang, Jianying Han, Huanqin Dai, Ronald J. Quinn, Hung-wen Liu, Houwei Luo, Lixin Zhang , Xueting Liu

July 28, 2017

  • Year

  • Technique

  • Industry

Title

Fungal biotransformation of tanshinone results in [4+2] cycloaddition with sorbicillinol: evidence for enzyme catalysis and increased antibacterial activity

Author

Wenni He, Miaomiao Liu, Xiaolin Li, Xiaoping Zhang, Wael M. Abdel-Mageed, Li Li, Wenzhao Wang, Jingyu Zhang, Jianying Han, Huanqin Dai, Ronald J. Quinn, Hung-wen Liu, Houwei Luo, Lixin Zhang , Xueting Liu

Year

2016

Journal

Biotechnological Products and Process Engineering

Abstract

The biotransformation of tanshinone IIA to a new antibacterial agent tanshisorbicin (1) by the fungusHypocrea sp. (AS 3.17108) is described. The structure of tanshisorbicin is a hybrid of tanshinone IIA (2) and sorbicillinol (3). The latter is a metabolite produced by Hypocrea sp. The structure of tanshisorbicin was determined using mass spectrometry, NMR spectroscopy, and ECD calculations. The anti-MRSA activity of 1 was found to be significantly higher than that of the parent substrate Tan IIA. Preliminary experiments indicate that tanshisorbicin is formed via a [4+2] cycloaddition reaction that is likely catalyzed by microbial enzyme.

Full Article

http://link.springer.com/article/10.1007/s00253-016-7488-6

Instrument

J-815

Keywords

Circular dichroism, Stereochemistry, Pharmaceutical